Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
VRSN vs NTCT vs AKAM vs FFIV vs CSCO
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Software - Infrastructure
Software - Infrastructure
Communication Equipment
VRSN vs NTCT vs AKAM vs FFIV vs CSCO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Software - Infrastructure | Software - Infrastructure | Software - Infrastructure | Communication Equipment |
| Market Cap | $25.54B | $2.77B | $17.18B | $19.50B | $364.95B |
| Revenue (TTM) | $1.68B | $861M | $4.27B | $3.22B | $59.05B |
| Net Income (TTM) | $841M | $96M | $435M | $708M | $11.08B |
| Gross Margin | 88.3% | 79.2% | 57.2% | 81.9% | 64.4% |
| Operating Margin | 67.9% | 12.8% | 13.7% | 24.6% | 23.0% |
| Forward P/E | 28.7x | 15.9x | 17.0x | 20.9x | 22.2x |
| Total Debt | $1.80B | $76M | $6.91B | $493M | $29.64B |
| Cash & Equiv. | $308M | $457M | $930M | $1.34B | $9.47B |
VRSN vs NTCT vs AKAM vs FFIV vs CSCO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| VeriSign, Inc. (VRSN) | 100 | 127.1 | +27.1% |
| NetScout Systems, I… (NTCT) | 100 | 139.4 | +39.4% |
| Akamai Technologies… (AKAM) | 100 | 110.3 | +10.3% |
| F5, Inc. (FFIV) | 100 | 238.1 | +138.1% |
| Cisco Systems, Inc. (CSCO) | 100 | 192.7 | +92.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VRSN vs NTCT vs AKAM vs FFIV vs CSCO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VRSN carries the broadest edge in this set and is the clearest fit for quality and stability.
- 50.0% margin vs AKAM's 10.2%
- Beta 0.13 vs NTCT's 1.12
- 69.9% ROA vs AKAM's 3.9%
NTCT is the #2 pick in this set and the best alternative if value and momentum is your priority.
- Lower P/E (15.9x vs 22.2x)
- +80.5% vs VRSN's -2.0%
AKAM is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.73, current ratio 2.29x
FFIV ranks third and is worth considering specifically for growth exposure and valuation efficiency.
- Rev growth 9.7%, EPS growth 23.6%, 3Y rev CAGR 4.6%
- PEG 1.12 vs AKAM's 7.00
- 9.7% revenue growth vs NTCT's -0.8%
CSCO is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 15 yrs, beta 0.92, yield 1.7%
- 301.7% 10Y total return vs FFIV's 238.7%
- Beta 0.92, yield 1.7%, current ratio 1.00x
- 1.7% yield, 15-year raise streak, vs VRSN's 0.8%, (3 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.7% revenue growth vs NTCT's -0.8% | |
| Value | Lower P/E (15.9x vs 22.2x) | |
| Quality / Margins | 50.0% margin vs AKAM's 10.2% | |
| Stability / Safety | Beta 0.13 vs NTCT's 1.12 | |
| Dividends | 1.7% yield, 15-year raise streak, vs VRSN's 0.8%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +80.5% vs VRSN's -2.0% | |
| Efficiency (ROA) | 69.9% ROA vs AKAM's 3.9% |
VRSN vs NTCT vs AKAM vs FFIV vs CSCO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
VRSN vs NTCT vs AKAM vs FFIV vs CSCO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FFIV leads in 2 of 6 categories
VRSN leads 1 • NTCT leads 1 • CSCO leads 1 • AKAM leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
VRSN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CSCO is the larger business by revenue, generating $59.1B annually — 68.6x NTCT's $861M. VRSN is the more profitable business, keeping 50.0% of every revenue dollar as net income compared to AKAM's 10.2%. On growth, FFIV holds the edge at +11.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.7B | $861M | $4.3B | $3.2B | $59.1B |
| EBITDAEarnings before interest/tax | $1.2B | $171M | $1.1B | $867M | $16.1B |
| Net IncomeAfter-tax profit | $841M | $96M | $435M | $708M | $11.1B |
| Free Cash FlowCash after capex | $1.0B | $275M | $765M | $963M | $12.8B |
| Gross MarginGross profit ÷ Revenue | +88.3% | +79.2% | +57.2% | +81.9% | +64.4% |
| Operating MarginEBIT ÷ Revenue | +67.9% | +12.8% | +13.7% | +24.6% | +23.0% |
| Net MarginNet income ÷ Revenue | +50.0% | +11.1% | +10.2% | +22.0% | +18.8% |
| FCF MarginFCF ÷ Revenue | +62.3% | +32.0% | +17.9% | +29.9% | +21.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.6% | -0.5% | +5.8% | +11.0% | +9.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +11.4% | +11.9% | -13.4% | +4.0% | +29.5% |
Valuation Metrics
NTCT leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 29.2x trailing earnings, FFIV trades at a 23% valuation discount to AKAM's 38.0x P/E. Adjusting for growth (PEG ratio), FFIV offers better value at 1.56x vs VRSN's 7.03x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $25.5B | $2.8B | $17.2B | $19.5B | $365.0B |
| Enterprise ValueMkt cap + debt − cash | $27.0B | $2.4B | $23.2B | $18.6B | $385.1B |
| Trailing P/EPrice ÷ TTM EPS | 31.61x | -7.57x | 38.01x | 29.24x | 36.14x |
| Forward P/EPrice ÷ next-FY EPS est. | 28.74x | 15.87x | 17.02x | 20.93x | 22.18x |
| PEG RatioP/E ÷ EPS growth rate | 7.03x | — | 7.00x | 1.56x | — |
| EV / EBITDAEnterprise value multiple | 23.46x | — | 17.32x | 21.73x | 26.34x |
| Price / SalesMarket cap ÷ Revenue | 15.41x | 3.36x | 4.08x | 6.31x | 6.44x |
| Price / BookPrice ÷ Book value/share | — | 1.78x | 3.45x | 5.64x | 7.87x |
| Price / FCFMarket cap ÷ FCF | 23.90x | 13.11x | 24.57x | 21.51x | 27.46x |
Profitability & Efficiency
FFIV leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CSCO delivers a 23.2% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $6 for NTCT. NTCT carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to AKAM's 1.39x. On the Piotroski fundamental quality scale (0–9), VRSN scores 8/9 vs AKAM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +6.1% | +9.1% | +19.9% | +23.2% |
| ROA (TTM)Return on assets | +69.9% | +4.3% | +3.9% | +11.2% | +9.0% |
| ROICReturn on invested capital | — | -19.3% | +4.7% | +21.8% | +13.0% |
| ROCEReturn on capital employed | — | -18.5% | +6.7% | +17.3% | +13.7% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 6 | 5 | 8 | 8 |
| Debt / EquityFinancial leverage | — | 0.05x | 1.39x | 0.14x | 0.63x |
| Net DebtTotal debt minus cash | $1.5B | -$381M | $6.0B | -$852M | $20.2B |
| Cash & Equiv.Liquid assets | $308M | $457M | $930M | $1.3B | $9.5B |
| Total DebtShort + long-term debt | $1.8B | $76M | $6.9B | $493M | $29.6B |
| Interest CoverageEBIT ÷ Interest expense | 22.79x | 55.89x | 8.85x | — | 9.64x |
Total Returns (Dividends Reinvested)
FFIV leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in FFIV five years ago would be worth $18,723 today (with dividends reinvested), compared to $10,531 for AKAM. Over the past 12 months, NTCT leads with a +80.5% total return vs VRSN's -2.0%. The 3-year compound annual growth rate (CAGR) favors FFIV at 36.7% vs VRSN's 8.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +16.1% | +42.6% | +37.1% | +34.4% | +22.3% |
| 1-Year ReturnPast 12 months | -2.0% | +80.5% | +40.8% | +29.0% | +57.5% |
| 3-Year ReturnCumulative with dividends | +28.1% | +30.3% | +47.1% | +155.5% | +109.3% |
| 5-Year ReturnCumulative with dividends | +26.3% | +42.9% | +5.3% | +87.2% | +87.2% |
| 10-Year ReturnCumulative with dividends | +233.2% | +66.6% | +132.7% | +238.7% | +301.7% |
| CAGR (3Y)Annualised 3-year return | +8.6% | +9.2% | +13.7% | +36.7% | +27.9% |
Risk & Volatility
Evenly matched — VRSN and FFIV each lead in 1 of 2 comparable metrics.
Risk & Volatility
VRSN is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than NTCT's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FFIV currently trades 99.3% from its 52-week high vs VRSN's 89.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.13x | 1.12x | 0.73x | 1.03x | 0.92x |
| 52-Week HighHighest price in past year | $310.60 | $39.24 | $122.22 | $347.47 | $94.72 |
| 52-Week LowLowest price in past year | $208.86 | $19.98 | $69.78 | $223.76 | $59.07 |
| % of 52W HighCurrent price vs 52-week peak | +89.7% | +97.6% | +95.5% | +99.3% | +97.3% |
| RSI (14)Momentum oscillator 0–100 | 60.5 | 68.6 | 70.9 | 69.3 | 63.9 |
| Avg Volume (50D)Average daily shares traded | 783K | 552K | 4.7M | 701K | 18.9M |
Analyst Outlook
CSCO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: VRSN as "Buy", NTCT as "Hold", AKAM as "Hold", FFIV as "Hold", CSCO as "Buy". Consensus price targets imply 27.5% upside for VRSN (target: $355) vs -24.3% for NTCT (target: $29). For income investors, CSCO offers the higher dividend yield at 1.75% vs VRSN's 0.83%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $355.00 | $29.00 | $111.18 | $310.67 | $96.50 |
| # AnalystsCovering analysts | 14 | 21 | 52 | 61 | 73 |
| Dividend YieldAnnual dividend ÷ price | +0.8% | — | — | — | +1.7% |
| Dividend StreakConsecutive years of raises | 0 | — | — | — | 15 |
| Dividend / ShareAnnual DPS | $2.32 | — | — | — | $1.61 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.5% | +0.9% | +4.7% | +2.6% | +2.0% |
FFIV leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). VRSN leads in 1 (Income & Cash Flow). 1 tied.
VRSN vs NTCT vs AKAM vs FFIV vs CSCO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VRSN or NTCT or AKAM or FFIV or CSCO a better buy right now?
For growth investors, F5, Inc.
(FFIV) is the stronger pick with 9. 7% revenue growth year-over-year, versus -0. 8% for NetScout Systems, Inc. (NTCT). F5, Inc. (FFIV) offers the better valuation at 29. 2x trailing P/E (20. 9x forward), making it the more compelling value choice. Analysts rate VeriSign, Inc. (VRSN) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VRSN or NTCT or AKAM or FFIV or CSCO?
On trailing P/E, F5, Inc.
(FFIV) is the cheapest at 29. 2x versus Akamai Technologies, Inc. at 38. 0x. On forward P/E, NetScout Systems, Inc. is actually cheaper at 15. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: F5, Inc. wins at 1. 12x versus Akamai Technologies, Inc. 's 7. 00x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — VRSN or NTCT or AKAM or FFIV or CSCO?
Over the past 5 years, F5, Inc.
(FFIV) delivered a total return of +87. 2%, compared to +5. 3% for Akamai Technologies, Inc. (AKAM). Over 10 years, the gap is even starker: CSCO returned +301. 7% versus NTCT's +66. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VRSN or NTCT or AKAM or FFIV or CSCO?
By beta (market sensitivity over 5 years), VeriSign, Inc.
(VRSN) is the lower-risk stock at 0. 13β versus NetScout Systems, Inc. 's 1. 12β — meaning NTCT is approximately 757% more volatile than VRSN relative to the S&P 500. On balance sheet safety, NetScout Systems, Inc. (NTCT) carries a lower debt/equity ratio of 5% versus 139% for Akamai Technologies, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VRSN or NTCT or AKAM or FFIV or CSCO?
By revenue growth (latest reported year), F5, Inc.
(FFIV) is pulling ahead at 9. 7% versus -0. 8% for NetScout Systems, Inc. (NTCT). On earnings-per-share growth, the picture is similar: F5, Inc. grew EPS 23. 6% year-over-year, compared to -144. 4% for NetScout Systems, Inc.. Over a 3-year CAGR, AKAM leads at 5. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VRSN or NTCT or AKAM or FFIV or CSCO?
VeriSign, Inc.
(VRSN) is the more profitable company, earning 49. 8% net margin versus -44. 6% for NetScout Systems, Inc. — meaning it keeps 49. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VRSN leads at 67. 7% versus -44. 7% for NTCT. At the gross margin level — before operating expenses — VRSN leads at 88. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VRSN or NTCT or AKAM or FFIV or CSCO more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, F5, Inc. (FFIV) is the more undervalued stock at a PEG of 1. 12x versus Akamai Technologies, Inc. 's 7. 00x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, NetScout Systems, Inc. (NTCT) trades at 15. 9x forward P/E versus 28. 7x for VeriSign, Inc. — 12. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRSN: 27. 5% to $355. 00.
08Which pays a better dividend — VRSN or NTCT or AKAM or FFIV or CSCO?
In this comparison, CSCO (1.
7% yield), VRSN (0. 8% yield) pay a dividend. NTCT, AKAM, FFIV do not pay a meaningful dividend and should not be held primarily for income.
09Is VRSN or NTCT or AKAM or FFIV or CSCO better for a retirement portfolio?
For long-horizon retirement investors, VeriSign, Inc.
(VRSN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 0. 8% yield, +233. 2% 10Y return). Both have compounded well over 10 years (VRSN: +233. 2%, NTCT: +66. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VRSN and NTCT and AKAM and FFIV and CSCO?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
VRSN, CSCO pay a dividend while NTCT, AKAM, FFIV do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.